A 28-year-old woman with primary infertility for 2 years presents for evaluation. Her menstrual cycles are regular (28 days), and general examination is normal. Her BMI is 22 kg/m². Husband's semen analysis is normal. Hysterosalpingography shows patent tubes bilaterally. Serum progesterone on day 21 of the cycle is 18 ng/mL. What is the most appropriate next step in management?

Explanation

## Clinical Assessment This patient has: - **Regular menstrual cycles (28 days)** — strongly suggests ovulation is occurring - **Normal BMI (22 kg/m²)** — no PCOS or obesity-related anovulation - **Normal semen analysis** — male factor ruled out - **Patent tubes bilaterally on HSG** — gross tubal obstruction excluded - **Serum progesterone 18 ng/mL on day 21** — this is **well within the ovulatory range** (>15 ng/mL confirms ovulation; Williams Gynecology; Berek & Novak's Gynecology) ## Diagnosis: Unexplained Infertility **Key Point:** A day-21 progesterone of **18 ng/mL confirms ovulation** has occurred. With ovulation confirmed, normal semen analysis, and patent tubes on HSG, the diagnosis is **unexplained infertility**. The next step is to investigate peritoneal factors that HSG cannot detect. ## Why Diagnostic Laparoscopy? **High-Yield:** In unexplained infertility, after ruling out anovulation, male factor, and gross tubal disease, the next step is **diagnostic laparoscopy** to identify peritoneal factors — most importantly **endometriosis** — that HSG cannot detect. - HSG demonstrates tubal patency but **cannot visualize peritoneal endometriosis, peritubal adhesions, or subtle tubal dysfunction** - Endometriosis is present in **30–50% of women with unexplained infertility** (Berek & Novak's Gynecology, 16th ed.) - Laparoscopy is the **gold standard** for diagnosing endometriosis and peritoneal adhesions - Absence of classic symptoms (dysmenorrhea, dyspareunia) does **not** exclude endometriosis — minimal/mild endometriosis is frequently asymptomatic **Clinical Pearl:** The standard workup for unexplained infertility (after confirming ovulation, normal semen analysis, and patent tubes) includes laparoscopy to rule out peritoneal pathology before proceeding to empirical ovulation induction or ART. This is consistent with FOGSI and RCOG guidelines. ## Why Not the Other Options? | Option | Rationale for Rejection | |--------|------------------------| | **Clomiphene citrate** | Ovulation is already confirmed (progesterone 18 ng/mL). Empirical clomiphene is not indicated when ovulation is occurring normally; it would be premature before completing the infertility workup. | | **Repeat progesterone** | Progesterone of 18 ng/mL already confirms ovulation; repeating it adds no diagnostic value and delays management. | | **Proceed to IVF** | IVF is reserved for failed conservative management, severe male factor, bilateral tubal block, or failed ovulation induction. First-line workup is incomplete. | ## Management Algorithm ``` Unexplained Infertility (ovulation confirmed, normal semen, patent tubes) ↓ Diagnostic Laparoscopy ↓ Endometriosis/adhesions found? → Treat surgically ↓ No peritoneal pathology → Empirical ovulation induction (Clomiphene/Letrozole + IUI) ↓ Failure after 3–6 cycles → IVF ``` **Key Point:** Diagnostic laparoscopy is the most appropriate next step in this case of unexplained infertility, as it can identify peritoneal pathology (especially endometriosis) that is not detectable by HSG. Clomiphene citrate is indicated for **anovulation** or **unexplained infertility after completing the workup**, not as the next step when ovulation is already confirmed and laparoscopy has not yet been performed (Berek & Novak's Gynecology; FOGSI guidelines).